港股異動 | 中國重汽漲超5%刷新階段新高 行業拐點已至
格隆匯1月31日丨中國重汽(3808.HK)拉昇漲超5%,盤中高見13.98港元刷新階段高價,總市值達380億港元。公司2022年度淨利潤1.76億元–2.6億元。中信證券表示,重卡行業大週期維度的拐點已至,行業有望迎來複蘇與增長。該行預測2023年重卡行業銷量約90萬輛,同比增長32%。有分析稱,2023年對於不少行業而言將代表着真正的復甦,特別是基建投資、物流運輸的全面恢復,對於重卡行業而言是絕對的利好,觸底反彈是必然。此外,12月重卡品牌價值傳播指數發佈,中國重汽排在了第一位,指數值為707.28。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.